Der Vortrag „Overflow and Functional Incontinence: Pharmacological and Behavioral Approaches“ von Kimberly Posey, AGPCNP-BC, DNP, PhD, GS-C ist Bestandteil des Kurses „Management of Genitourinary and Nephrological System Disorders in the Older Adult“.
Which pharmacologic approach is recommended as first-line treatment for benign prostatic hyperplasia (BPH) causing overflow incontinence?
Which of the following medication classes is a common contributor to medication-induced urinary retention?
In a mixed incontinence case, which mobility finding from standardized assessment tools suggests the patient is clinically deteriorating and at risk for falls?
| 5 Sterne |
|
5 |
| 4 Sterne |
|
0 |
| 3 Sterne |
|
0 |
| 2 Sterne |
|
0 |
| 1 Stern |
|
0 |